Increased cerebral and renal endothelial nitric oxide synthase gene expression after cardiopulmonary bypass in the rat  by Mazer, C. David et al.
I
s
t
C
Z
G
Mazer et al Cardiopulmonary Support and Physiology
CS
Pncreased cerebral and renal endothelial nitric oxide
ynthase gene expression after cardiopulmonary bypass in
he rat
. David Mazer, MD,a,b Francoise Briet, PhD,a Katherine R. Blight, MD,a Duncan J. Stewart, MD,c Malcolm Robb, PhD,c
hilan Wang, MSc,a Alana M. Harrington, HBSc,a William Mak, PhD,a,d Xiaomao Li, PhD,a,d and
regory M. T. Hare, MD, PhDa,b
O
p
T
a
i
M
b
h
e
r
o
R
t
C
i
4
m
c
f
s
C
e
w
a
o
m
c
N
s injury
a gan
i
e
o ch asSupplemental material is
available online.
From the Departments of Anesthesiaa and
Physiologyb and the Division of Cardiol-
ogy,c University of Toronto, St. Michael’s
Hospital, and the Biotechnology Centre for
Applied Research and Training,d Seneca
College, Toronto, Ontario, Canada.
Supported by St Michael’s Hospital, Ane-
mia Institute for Research and Education,
Physicians’ Services Incorporated Founda-
tion, Canadian Anesthesiologists’ Society.
Dr Hare is a recipient of the Bristol-Myers
Squibb-Canadian Anesthesiologists’ Soci-
ety Career Scientist Award.
This work is attributed to the Department of
Anesthesia, St Michael’s Hospital, Univer-
sity of Toronto.
Presented in part at the Society of Cardio-
vascular Anesthesiologists Meeting, Mi-
ami, Fla, April 29, 2003.
Received for publication Oct 19, 2005; re-
visions received May 17, 2006; accepted
for publication June 13, 2006.
Address for reprints: C David Mazer, MD,
Professor, Department of Anesthesia, Univer-
sity of Toronto, St Michael’s Hospital, 30
Bond St, Toronto, Ontario, M5B 1W8 Can-
ada (E-mail: mazerd@smh.toronto.on.ca).
J Thorac Cardiovasc Surg 2007;133:13-20
0022-5223/$32.00
Copyright © 2007 by The American Asso-
ciation for Thoracic Surgeryl
doi:10.1016/j.jtcvs.2006.06.047bjective: Hemodilution and endothelial nitric oxide synthase genetic polymor-
hism may contribute to cerebral and renal injury after cardiopulmonary bypass.
his study tested the hypothesis that cardiopulmonary bypass and anemia stimulate
n increase in cerebral and renal endothelial nitric oxide synthase gene expression
n an experimental model of cardiopulmonary bypass.
ethods: Anesthetized rats underwent a sham procedure without cardiopulmonary
ypass (sham, n 5), normothermic bypass for 1 hour (CPB, n 7), or bypass plus
emodilutional anemia (CPB anemia, n  9). After 24 hours of recovery, RNA was
xtracted from the cerebral cortex, renal cortex, and renal medulla. Quantitative
everse transcriptase polymerase chain reaction was used to assess endothelial nitric
xide synthase messenger RNA levels in brain and kidney tissues.
esults: The hemoglobin concentration of anemic CPB rats was significantly lower
han that of nonanemic rats on bypass (64  5 vs 99  8 g · L1, P  .001).
erebral cortical endothelial nitric oxide synthase messenger RNA levels were
ncreased after cardiopulmonary bypass relative to those of the sham group (11.2 
.2 vs 6.3  1.5 fg, P  .031), without a further increase in anemic rats. Renal
edullary endothelial nitric oxide synthase messenger RNA levels were signifi-
antly higher in the CPB anemia group than in the sham and CPB groups (7.1 4.4
g vs 1.8  0.4 fg vs 3.0  0.6 fg, P  .001). Renal cortical endothelial nitric oxide
ynthase messenger RNA levels did not change significantly.
onclusions: Normothermic cardiopulmonary bypass was associated with higher
ndothelial nitric oxide synthase messenger RNA levels in kidney and brain than
as the sham procedure 24 hours after cardiopulmonary bypass. Anemia accentu-
ted the increase in renal medullary, but not cerebral cortical, endothelial nitric
xide synthase expression. These data provide an approach for exploring potential
echanisms by which endothelial nitric oxide synthase may contribute to renal and
erebral dysfunction after cardiopulmonary bypass and anemia.
eurologic and renal injury after cardiopulmonary bypass (CPB) causes
significant morbidity in patients undergoing cardiac surgery.1-4 Recent
studies have demonstrated that hemodilution and endothelial nitric oxide
ynthase (eNOS) gene polymorphisms may contribute to cerebral and renal 
fter CPB.2,4-7 Experimental studies have implicated potential mediators of or
njury after CPB, including embolic events,8 inflammatory mediators,3 neuronal
xcitotoxicity,9 apoptosis,10 and inadequate tissue perfusion.7,11,12 Inadequacies in
rgan perfusion during CPB may be exaggerated under extreme conditions, su
ow hematocrit, in which tissue oxygen delivery is further compromised.13
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CSPConstitutive nitric oxide synthases (NOS), including
NOS and neuronal NOS (nNOS), regulate a number of
hysiologic functions, including cerebral and renal perfu-
ion.14 Experimental studies using nonspecific inhibitors 
NOS and nNOS have demonstrated that NOS activity
ontributes to the regulation of cerebral blood flow du
emodilution, CPB, and after circulatory arrest.15-17 How-
ver, the specific role of eNOS after CPB has not been fully
haracterized in an experimental model of CPB.
Clinical studies have implicated acute hemodilutional
nemia and eNOS gene polymorphism with renal and ce-
ebral injury after CPB, emphasizing the need to develop
xperimental models that will help to define the relationship
f eNOS and CPB. The main objective of this study was to
etermine whether CPB and anemia, in the absence of
ternotomy, hypothermia, or cardioplegia, could influence
NOS expression in the brain and kidney 24 hours after
PB.
aterials and Methods
nimal Model and Surgical Preparation
ll animal protocols were approved by the Animal Care and Use
ommittee at St Michael’s Hospital in accordance with the re-
uirements of the Canadian Animal Care Committee. Male
prague-Dawley rats (Charles River, St Constant, Quebec, Can-
da) weighing approximately 400 g were assigned to one of three
roups: sham, CPB, and CPB anemia. Sham-operated rats under-
ent all surgical procedures but were not placed on CPB (sham, n
5). CPB rats were exposed to 1 hour of CPB (CPB, n  7), and
PB anemia rats underwent 1 hour of CPB with hemodilutional
nemia (CPB anemia, n  9). Anesthesia was induced in all CPB
nd sham animals with ketamine (100 mg · kg1 intraperitoneal
IP]; Parke-Davis/Bayer, Toronto, Ontario, Canada) and glycopy-
rolate (0.2 mg · kg1 IP; Sabex, Boucherville, Quebec, Canada).
he trachea was intubated with a 14-gauge catheter (BD Bio-
ciences, Mississauga, Ontario, Canada) and the lungs mechani-
ally ventilated with 100% oxygen using a pressure control ven-
ilator (Kent Scientific, Litchfield, Conn) to maintain a PaCO2 of 35
o 45 mm Hg. All cannulation sites were infiltrated with 1%
Abbreviations and Acronyms
cDNA  complementary DNA
CPB  cardiopulmonary bypass
eNOS  endothelial nitric oxide synthase
IP  intraperitoneal
IV  intravenous
nNOS  neuronal nitric oxide synthase
NOS  nitric oxide synthase
PCR  polymerase chain reaction
RT-PCR reverse transcriptase polymerase chain
reaction
VEGF  vascular endothelial growth factoridocaine (Xylocaine; Astra Pharma Inc, Mississauga, Ontario, A
4 The Journal of Thoracic and Cardiovascular Surgery ● Januaanada) before surgical incisions were performed. Anesthesia was
aintained with 1% to 2% isoflurane (Abbott Laboratories, St
aurent, Quebec, Canada). The tail artery was cannulated with a
2-gauge catheter for direct blood pressure measurement and
lood sampling for blood gas analysis and measurement of hemo-
lobin concentration using co-oximetry (Radiometer ALB 500 and
SM 3, London Scientific, London, Ontario, Canada). Heparin
200 IU intravenous [IV]; Leo Pharma, Thornhill, Canada) and
efazolin (10 mg · kg1 IV; Eli Lilly, Toronto, Ontario, Canada)
ere given after cannulation of the common jugular vein. Rectal
emperature was monitored, and a heating pad and radiant lamp
ere used to keep the core temperature near 37°C. Mean arterial
ressure, core temperature, arterial blood gases, and co-oximetry
easurements were performed and recorded every 15 minutes
efore, during, and after CPB. A separate group of rats was
xposed to 10% oxygen for 24 hours, without any anesthesia or
urgical manipulation (hypoxia, n  5). These hypoxic controls
ere used to provide cerebral cortical tissue to serve as a positive
ontrol for hypoxic gene expression (vascular endothelial growth
actor, VEGF).
PB
n established model of normothermic CPB was used to study the
solated effect of CPB on cerebral and renal eNOS gene expression
n the absence of significant stimuli from sternotomy, aortic cross-
lamp, hypothermia, or cardioplegia-induced cardiac ar-
est.7,10,13,18 Venous access for CPB was obtained by cannula
he right common jugular vein with a modified multiorificed
auge catheter (BD Biosciences, modified in our laboratory),
hich was placed at the junction of the vena cava and right atrium.
he venous catheter was connected to a venous reservoir with
ilicone tubing (Masterflex; Cole-Parmer Instruments, Niles, Ill).
rterial access was achieved by cannulating the left carotid artery
ith a 20-gauge catheter (BD Biosciences). The CPB circuit was
rimed with approximately 40 mL of blood obtained from 2
eparinized donor rats (400 IU · kg1 heparin IV), which were
xsanguinated under general anesthesia before the beginning of the
xperiment. Pentastarch (Pentaspan; Bristol-Myers Squibb, Mon-
real, Quebec, Canada) was added to the circuit prime to achieve a
arget hemoglobin concentration of 100 g · L1. Throughout the
xperiment, the hemoglobin was maintained near 100 g · L1 in
ham and CPB rats. In the CPB anemia group, further hemodilu-
ion with pentastarch was performed to a target hemoglobin con-
entration near 65 g · L1. Blood was pumped from the venous
eservoir through a modified neonatal membrane oxygenator
Cobe Cardiovascular, Arvada, Colo) using a calibrated roller
ump (Masterflex). Oxygenated blood was returned to the animal
ia the carotid cannula. The target CPB flow rates (150 mL · kg1
 min1) were based on other rat CPB studies and the n
ardiac output of the rat.9,10 This previously established and va-
dated model of CPB does not include potential confounders such
s sternotomy, cardioplegia, crossclamping, hypothermia, and un-
erlying comorbidities.9,10
Before initiation of CPB, the anesthetic was changed from an
nhalational anesthetic to an intravenous anesthetic consisting of
entanyl (6-12 g · kg1 · h1; Abbott), midazolam (60-120 g ·
g1 · h1; Sabex), and cis-atracurium (1-2 mg · kg1 · h1;
bbott). After 60 minutes of CPB, the animals were weaned from
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Phe bypass circuit and protamine (5 mg · kg1; Sabex) was ad-
inistered via the jugular vein. The animals were then decannu-
ated and remained anesthetized and ventilated until spontaneous
entilation resumed. Furosemide (0.5 mg · kg1 IP; Sabex) was
dministered before extubation. After tracheal extubation, the an-
mals were allowed to recover in an oxygen-enriched environment
or 1 to 2 hours before being returned to room air. Free access to
ood and water was provided during recovery.
The CPB and sham rats underwent identical surgical prepara-
ion including cannulation, mild hemodilution, and anesthetic con-
itions. Thus, after cannulation of the sham rats, the anesthetic was
witched to an intravenous technique for 60 minutes, but the rats
ere not connected to the CPB circuit.
rain and Kidney Harvesting for RNA Extraction and
everse Transcriptase Polymerase Chain Reactions
RT-PCR)
fter 24 hours of recovery following CPB or sham operation, rats
ere anesthetized with ketamine (100 mg · kg1 IP; Parke-Davis/
ayer, Toronto, Ontario, Canada) and then decapitated. Sections
f cerebral cortical, renal cortical, and renal medullary tissue were
ash frozen in liquid nitrogen within 6 minutes of decapitation and
tored at 80°C until RNA extraction was performed. After me-
hanical disruption by homogenization of about 30 mg of tissue,
otal RNA was extracted by standard techniques (RNeasy Mini
it; Qiagen, Mississauga, Ontario, Canada). The optical density
60/280  was determined with 10 L of sample and the sample
as divided into 4-L aliquots (about 0.2 g · L1) and frozen
80°C).
T-PCR
nitial assessment of cerebral cortical eNOS messenger RNA
mRNA) levels was performed by standard RT-PCR and agarose
el electrophoresis with newly generated primers based on the rat
omplementary DNA (cDNA) sequence (GeneTool 1.0; BioTools
nc, Edmonton, Alberta, Canada) (Table E1). Measurement 
tandard control gene (glyceraldehyde-3-phosphate dehydrogenase
GAPDH]) was performed with previously described primers to
rovide RNA measurements of a reference gene that was not
xpected to change in response to CPB or anemia. The OneStep
T-PCR Kit was used for quantification of RNA levels according
o the manufacturer’s protocol (Qiagen Inc, Mississauga, Ontario,
anada). Serial dilutions were used to determine whether the
eneration of RT-PCR product was linear with respect to the
mount of RNA used for reverse transcription. All PCR products
nderwent standard agarose gel electrophoresis. On each 1.5%
garose gel, RT-PCR product from a single sham and CPB cere-
ral cortex sample were loaded in triplicate. Gel band densities
ere digitized and quantified with a computerized digital imaging
ystem (AlphaImager, 8-bit digital camera; Canberra Packard,
oronto, Ontario, Canada). All band densities are expressed in
ixels. This method was performed to establish whether cerebral
ortical eNOS expression was increased after CPB. After this
nding was established, all other assessments were performed by
uantitative RT-PCR as described below.
Quantitative RT-PCR was performed by established methods.
n brief, reverse transcription of 1 g of total RNA to cDNA was
erformed with the use of the Moloney-Murine Leukemia Virus 5
The Journal of Thoraceverse Transcriptase and random primers, according to the man-
facturer’s protocol (Invitrogen, Burlington, Ontario, Canada).
eal-time quantitative PCR was performed by measuring the
YBR Green fluorescent dye incorporation during double-strand
NA synthesis using the ABI 7900HT Sequence Detection Sys-
em (Applied Biosystems, Foster City, Calif). With the use of the
escribed ABI method, gene-specific primers for GAPDH, eNOS,
nd VEGF164 were designed to be suitable for annealing at 62°C,
anging in size from 23 to 26 bases (Table E1). The PCR p
ize limitation was between 95 and 350 bases. Gene-specific PCR
roducts were generated with DNA polymerase (SYBR Green
CR Master Mix; Applied Biosystems). In brief, 40 PCR cycles
ere performed including denaturing at 95°C for 15 seconds,
nnealing, and extension at 62°C for 1 minute. The target tran-
cript quantities were determined by measuring the PCR product
gainst a 5-point standard curve. The standard curves were gen-
rated for GAPDH, eNOS, and VEGF using a double-stranded
NA template constructed to match the sequence between the 5=
nds of the forward and reverse primers, relative to their cDNAs
Qiagen/Operon). The standard curve values ranged from 10 to
.001 pg for GAPDH. For the target genes eNOS and VEGF164,
tandard curve values ranged from 1000 to 0.1 fg. Quantitative
CR products are reported in picograms or femtograms. Once PCR
roducts were obtained, melting curve analysis was performed to
erify the specificity and identity of the PCR products. Assessment
f VEGF was included because this gene is known to be up-
egulated by hypoxia. Measurement of VEGF mRNA levels
elped to determine whether any significant degree of renal or
erebral hypoxia occurred in the CPB animals.
tatistical Analyses
tatistical analyses were performed with the Statistical Package for
he Social Sciences for Windows, version 11.0.0 (SPSS Inc, Chi-
ago, Ill). Physiologic data were assessed for any time and group
ffect by a 2-way analysis of variance for main and interaction
ffects. Post hoc analysis was performed by the Tukey test. RT-
CR data were assessed by a Kruskal-Wallis 1-way analysis of
ariance on ranks and post hoc Dunn test. Data are reported as
ean  standard deviation.
esults
hysiologic Data: Hemoglobin Concentration and
lood Gas Analysis
n all three groups, the core temperature and mean arterial
ressure remained stable without any significant differences
etween groups at any time period (Figure 1). There 
o differences between groups in baseline hemoglobin con-
entrations (Figure 1). As intended, the hemoglobin c
entration decreased in the sham and both CPB groups
ccording to the protocol. There were no significant differ-
nces in hemoglobin concentration between the CPB and
ham groups at any time (Figure 1). In the CPB a
roup, a more severe degree of hemodilution was per-
ormed. Thus, the hemoglobin concentration in the CPB
nemia group remained significantly lower than that in the
PB group at all time points during CPB (Figure 1, 
g · L1, P  .001). Arterial blood gas data demonstrated
ic and Cardiovascular Surgery ● Volume 133, Number 1 15
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CSP
o significant difference in pH, PaCO2, or PaO2 among sham,
PB, and CPB anemia animals. In all cases, the pH was
aintained near 7.4, the PaCO2 was near 30 to 40 mm Hg,
nd the PaO2 was above 2500 mm Hg (Figure 1).
erebral Cortical eNOS mRNA Levels (Conventional
T-PCR)
ll PCR products were generated in a linear fashion and
roduced clear PCR product bands near the expected mo-
ecular weight. Agarose gel electrophoresis demonstrated
hat cerebral cortical eNOS mRNA levels were significantly
levated relative to sham 24 hours after CPB (9430  2391
s 5408 2792 pixels/ng total RNA, P .016). There were
Figure 1. Left panels, Rectal temperature (upper left
hemoglobin concentration (lower left panel) in sham (
triangle) rats. The initial measurement at baseline was
minutes). The initial drop in hemoglobin occurred as
decrease was significantly greater in anemic rats, whi
were no significant differences in mean arterial pressu
right panel), PaCO2 (middle right panel), and PaO2 (low
were no significant differences in pH, PaCO2 and PaO2 w
*P < .05 relative to baseline and between groups. CPo significant differences in GAPDH mRNA levels between V
6 The Journal of Thoracic and Cardiovascular Surgery ● Januaham and CPB rats (3679 1527 vs 3566 1114 pixels/ng
otal RNA).
erebral Cortical eNOS and VEGF mRNA Levels
Quantitative RT-PCR)
onfirmation of the increase in cerebral cortical eNOS
RNA after CPB was achieved by using primers to a
ifferent segment of the rat eNOS gene (Table E1). 
ime RT-PCR demonstrated an increase in cerebral cortical
NOS mRNA after CPB (11.2  4.2 fg) relative to sham
6.3  1.5 fg) (Figure 2, P  .031). No further significan
hanges in eNOS mRNA levels were measured in the CPB
nemia group. Messenger RNA levels for cerebral cortical
el), mean arterial pressure (middle left panel), and
d circle), CPB (open circle), and CPB anemia (closed
pared with values during 1 hour of CPB (CPB, 15 to 75
ult of mild hemodilution in sham and CPB rats. This
derwent a more severe degree of hemodilution. There
temperature between groups. Right panels, pH (upper
ht panel) in sham, CPB, and CPB anemia rats. There
CPB, CPB anemia, and sham animals were compared.
rdiopulmonary bypass.pan
close
com
a res
ch un
re or
er rig
hen
B, caEGF were significantly reduced after CPB (10.9  5.4 fg)
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Pnd CPB anemia (Figure 2, P  .012). By contrast, VEG
RNA levels were increased after hypoxia exposure (55.2
18.3 fg) relative to sham animals (24.2  7.6 fg) (P 
016). No differences in GAPDH mRNA levels were ob-
erved among the three groups.
enal Cortical and Medullary eNOS and VEGF
RNA Levels (Quantitative RT-PCR)
enal cortical eNOS mRNA values were not statistically
ifferent among groups after CPB, CPB anemia, or sham
sham 1.9  0.9 fg, CPB 1.8  0.9 fg, and CPB anemia 3.6
 2.2 fg, Figure 2, P  .140). By contrast, renal medulla
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Figure 2. Real time quantitative RT-PCR analyses of GAP
cortex, and renal medulla of sham, CPB, and CPB anem
GAPDH were observed among groups in any tissue. Cer
CPB, but not further increased by CPB and anemia. In
change in eNOS mRNA levels; however, CPB and an
medulla, CPB and anemia resulted in a large increase
increase in mRNA was observed for the hypoxic gene
reduction in VEGF mRNA levels in both the cerebral an
to the CPB group. PCR, polymerase chain reaction; GA
endothelial nitric oxide synthase; VEGF, vascular e
cardiopulmonary bypass.NOS levels tended to increase after CPB (3.0  0.6 fg) o
The Journal of Thoracelative to sham rats (1.8  0.4 fg) and were significantly
levated in the anemic rats after CPB (7.8  4.1 fg) (Figur
, P  .001). Renal cortical VEGF mRNA levels decrea
fter CPB in anemic rats (Figure 2, P  .001). No signifi
ant changes in renal cortical or medullary GAPDH gene
xpression were observed.
iscussion
his study demonstrates that eNOS mRNA levels are ele-
ated compared with sham control values in the cerebral
ortex and renal medulla 24 hours after CPB in a rat model
p=0.699
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1
CSPas most profoundly influenced by the combination of CPB
nd anemia. The increases in eNOS were not accompanied
y any significant changes in expression of the control gene
APDH, suggesting that CPB or the other experimental
echniques did not produce a nonspecific increase in gene
xpression. These data relate to the clinical findings that
enal dysfunction after CPB has been associated with low
ematocrit and eNOS gene polymorphism, suggesting that
his model of CPB may help to define the mechanism by
hich eNOS many protect from, or contribute to, organ
njury after CPB.2-6
Cerebral and renal dysfunction are significant determi-
ants of morbidity and mortality after CPB. In both cases,
ncreased renal and cerebral injury have been associated
ith the lowest hematocrit on CPB.2-6 This suggests that th
ombination of nonphysiologic circulation and altered ce-
ebral and renal perfusion may potentiate end-organ injury
fter CPB. Experimental studies have demonstrated that
raditional laminar perfusion may be inferior to biologically
ariable flow that more closely approximates physiologic
erfusion conditions.19 Therefore, standard continuous-flow
PB may provide suboptimal perfusion characteristics that
timulate compensatory mechanisms to improve organ
unction, including increased expression of cerebral and
enal eNOS. Severe hemodilutional anemia may lead to
urther reductions in tissue oxygen delivery2,4,5 and intro-
uce additional changes in shear forces,20 which may pro-
ide further stimuli for greater eNOS expression. This may
xplain the magnitude of the increase in renal medullary
NOS expression that occurred in anemic rats after CPB.
Endothelial NOS/nitric oxide is known to play an impor-
ant role in regulating vascular smooth muscle tone and
rgan perfusion.14,16,17,21,22 As such, greater cerebral an
enal eNOS expression after CPB could help to limit end-
rgan injury.16 Endothelial NOS/nitric oxide may also p-
ect against organ injury by limiting systemic inflam
ion,23 inhibiting leukocyte adhesion,24 and limiting platele
ggregation.25 Increased activity and expression of eNO
as been observed in myocardial tissue of patients un
oing cardiac surgery with CPB.26,27 In addition, eNOS
olymorphism has been associated with increased vascular
esponsiveness to vasocontrictors during CPB in human28
o our knowledge, this is the first study to examine eNOS
xpression in the brain and kidney after CPB. We chose to
easure gene expression 24 hours after CPB because other
xperimental models (hypoxia, brain injury) have demon-
trated a maximal biological effect of gene expression 18 to
4 hours after exposure to the stimulus and because cerebral
nd renal dysfunction may develop or be manifest in this
ime frame.29,30
Although most studies have suggested a protective ef-
ect, the possibility that eNOS expression may contribute to
rgan injury and dysfunction after CPB cannot be excluded. V
8 The Journal of Thoracic and Cardiovascular Surgery ● Januaxperimental models of CPB have implicated a number of
andidate mechanisms of injury, which include tissue h
xia,9,11,12 proapoptotic and antiapoptotic factors,10 cyclo-
xygenase, and inflammatory mediators.18,23,31 However,
he potential role of NOS in the pathophysiology of organ
erfusion and/or injury after CPB has not been elucidated.
Demonstration of increased renal medullary eNOS after
PB may have significant physiologic and pathophysiologic
mplications.14 Under resting conditions, relatively high e-
ression of eNOS has been previously demonstrated in the
enal medulla.32 Furthermore, renal hypoperfusion signifi-
antly increases renal medullary, but not cortical, eN
xpression.33 Such basal and stimulated expression 
NOS may be important to maintaining adequate perfu
o the relatively hypoxic renal medulla during and after
PB.7 In this study, the highest level of renal medu
NOS was seen in anemic rats undergoing CPB. This in-
rease in eNOS expression may be stimulated by reduced
xygen delivery and/or increased shear stress within 
asculature.20 In situations of extreme hemodilution, t
nd other protective mechanisms may be overwhelmed,
esulting in renal injury.2,4 Clinical studies have implicate
NOS genotype variation in the pathophysiology of renal
njury after CPB.3 Further research is required to assess 
ole of eNOS in renal injury after CPB.
The greater expression of cerebral and renal eNOS
RNA compared with sham after CPB in rats occurs within
4 hours after recovery from a 1-hour period of experimen-
al CPB. Measurement of cerebral cortical eNOS expression
emonstrated a significant increase after CPB with a mar-
inal P value of .031. This observation was obtained via
oth standard and quantitative PCR, on different cerebral
ortical tissue samples, with specific primers designed to
mplify two different regions of the eNOS gene. These two
ndependent measures support the likelihood that the in-
rease in cerebral cortical eNOS expression was a true
esult. During CPB, there was no evidence of systemic
ypotension, hypoxemia, or acidosis, suggesting that these
timuli were not responsible for the increase in eNOS
xpression.
Regulation of the hypoxic gene VEGF followed a dif-
erent pattern after CPB. The data demonstrate the follow-
ng: (1) cerebral cortical VEGF expression was reduced
fter CPB and CPB anemia; (2) renal cortical VEGF ex-
ression was reduced after CPB and anemia; and (3) renal
edullary VEGF mRNA levels did not change significantly
n any group. Since VEGF mRNA levels are up-regulated
y hypoxia, these responses suggest that significant tissue
ypoxia did not occur in either the brain or kidney during or
fter CPB. Although the mechanism by which eNOS ex-
ression is enhanced has not been defined, hypoxia is not a
ikely candidate on the basis of the observed reduction in
EGF expression. Levels of mRNA for the control gene
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PAPDH did not change significantly in brain or kidney in
ny of the groups studied, emphasizing that the observed
hanges in eNOS and VEGF represented specific physio-
ogic regulation of gene expression in response to CPB.
imitations
his study has some limitations. We used a previously
stablished and validated model of CPB that does not in-
lude sternotomy, cardioplegia, crossclamping, and under-
ying comorbidities to assess the effect of CPB on eNOS
xpression.10,18 Therefore, the effect of these clinically -
vant factors could not be assessed. The sample size in
tudy was based on previous data from our and other lab-
ratories, but the possibility of a type II error does exist. Our
tudy measured outcomes at only one time point. This was
hosen because other experimental models have demon-
trated a maximal biological effect of gene expression ap-
roximately 24 hours after exposure to the stimulus.29,30
owever, without baseline or immediate post-CPB samples,
e cannot exclude the possibility of an earlier effect. No
easurements of organ perfusion were performed and the
ink between eNOS mRNA levels and improved organ
erfusion is speculative. Histologic examination was not
erformed on our tissue samples, but previous work with
his model found no evidence of gross neuronal injury or
ecrosis.10 Future research will address the physiolog
ignificance, protein expression, and cellular localization of
he eNOS expression.
onclusions
n summary, experimental CPB and hemodilution resulted
n a significantly higher level of cerebral cortical and renal
edullary eNOS mRNA than was observed in similarly
nesthetized and instrumented sham animals. This occurred
n association with lower VEGF expression, suggesting that
issue hypoxia was not the stimulus for eNOS expression.
ecent clinical data suggest that genetic variability in the
NOS gene may contribute to renal dysfunction after CPB.
urther basic and clinical research will better define the role
f eNOS in cerebral and renal function during and after
PB.
We acknowledge the technical assistance of Ms Carla Coackley
nd Mr Rong Qu.
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PABLE E1. Summary of primers used for standard and rea
rimer Primer sequence (5’ -3=) Start, b
rimers for standard RT-PCR
APDH
Forward ACC ACC ATG GAG AAG GCT GG 331
Reverse CTC AGT GTA GCC CAG GAT GC
NOS
Forward CCC CCA GAC GGA CCC AAG TTT 188
Reverse GGG AAC ACC GTG ATG GCT GAA C
rimers for quantitative RT-PCR
APDH
Forward CTC TAA GGC TGT GGG CAA GGT CAT 655
Reverse GAG ATC CAC CAC CCT GTT GCT GTA
NOS
Forward TTG TGG ACC ACC ATG CCG CCA CAG 1247
Reverse AAG ACA GGG GTG AGG CTG CCT G
EGF164
Forward CAT AGG AGA GAT GAG CTT CCT GC 13
Reverse CTC TGA ACA AGG CTC ACA GTG ATT TTC
T-PCR, reverse transcriptase polymerase chain reaction; bp, base pair;
xide synthase; VEGF, vascular endothelial growth factor.l-time quantitative RT-PCR
p End, bp Size, bp Anneal temp, oC Cycle
Accession number/
(reference)
858 527 60 20 M17701 (Bona E, Pediatr
Res 1999;45:500-9)
699 511 62 32 AF085195
998 343 62 40 AF106860
1376 129 62 40 XM 342615
109 96 62 40 AF260425
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; eNOS, endothelial nitricThe Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 1 20.e1
